FINCH THERAPEUTICS GROUP, INC. Operating Income
FINCH THERAPEUTICS GROUP, INC. reported Operating Income of -$6.11 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2024-08-13
- FINCH THERAPEUTICS GROUP, INC. operating income (loss) for the quarter ending 2024-06-30 was -$6.11M.
- FINCH THERAPEUTICS GROUP, INC. operating income (loss) for the quarter ending 2024-03-31 was -$5.20M.
- FINCH THERAPEUTICS GROUP, INC. operating income (loss) for the quarter ending 2023-12-31 was -$4.42M.
- FINCH THERAPEUTICS GROUP, INC. operating income (loss) for the quarter ending 2023-09-30 was -$3.78M.
- FINCH THERAPEUTICS GROUP, INC. operating income (loss) for fiscal 2023 was -$83.86M.
- FINCH THERAPEUTICS GROUP, INC. operating income (loss) for fiscal 2022 was -$115.59M.
- FINCH THERAPEUTICS GROUP, INC. operating income (loss) for fiscal 2021 was -$59.98M.
- FINCH THERAPEUTICS GROUP, INC. operating income (loss) for fiscal 2020 was -$39.44M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|
| 2024-06-30 | -$6.11M 10-Q · filed 2024-08-13 | -$11.31M 10-Q · filed 2024-08-13 | -$15.72M derived: sum of 3 quarters · filed 2024-08-13 | -$19.50M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2024-03-31 | -$5.20M 10-Q · filed 2024-05-10 | -$9.61M derived: sum of 2 quarters · filed 2024-05-10 | -$13.39M derived: sum of 3 quarters · filed 2024-05-10 | -$23.28M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-12-31 | -$4.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$8.20M derived: sum of 2 quarters · filed 2024-03-25 | -$18.08M derived: sum of 3 quarters · filed 2024-08-13 | -$83.86M 10-K · filed 2024-03-25 | |
| 2023-09-30 | -$3.78M 10-Q · filed 2023-11-08 | -$13.66M derived: sum of 2 quarters · filed 2024-08-13 | -$79.44M 10-Q · filed 2023-11-08 | -$107.20M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-06-30 | -$9.88M 10-Q · filed 2024-08-13 | -$75.66M 10-Q · filed 2024-08-13 | -$103.42M derived: sum of 3 quarters · filed 2024-08-13 | -$144.05M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | -$65.78M 10-Q · filed 2024-05-10 | -$67.38M 10-Q · filed 2023-05-10 | -$93.53M derived: sum of 2 quarters · filed 2024-05-10 | -$134.17M derived: sum of 3 quarters · filed 2024-05-10 | -$156.80M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$27.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$68.38M derived: sum of 2 quarters · filed 2024-03-25 | -$91.01M derived: sum of 3 quarters · filed 2024-03-25 | -$115.59M 10-K · filed 2024-03-25 | |
| 2022-09-30 | -$40.63M 10-Q · filed 2023-11-08 | -$63.26M derived: sum of 2 quarters · filed 2023-11-08 | -$87.84M 10-Q · filed 2023-11-08 | -$106.90M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | -$22.63M 10-Q/A · filed 2023-08-11 | -$47.21M 10-Q/A · filed 2023-08-11 | -$66.27M derived: sum of 3 quarters · filed 2023-08-11 | -$76.20M derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | -$24.58M 10-Q · filed 2023-05-10 | -$43.64M derived: sum of 2 quarters · filed 2023-05-10 | -$53.58M derived: sum of 3 quarters · filed 2023-05-10 | -$70.59M derived: sum of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | -$19.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$29.00M derived: sum of 2 quarters · filed 2023-03-23 | -$46.01M derived: sum of 3 quarters · filed 2023-03-23 | -$59.98M 10-K · filed 2023-03-23 | |
| 2021-09-30 | -$9.93M 10-Q · filed 2022-11-10 | -$26.95M derived: sum of 2 quarters · filed 2022-11-10 | -$40.92M 10-Q · filed 2022-11-10 | -$54.05M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | -$17.02M 10-Q · filed 2022-08-11 | -$30.99M 10-Q · filed 2022-08-11 | -$44.12M derived: sum of 3 quarters · filed 2022-08-11 | -$54.20M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$13.97M 10-Q · filed 2022-05-16 | -$27.11M derived: sum of 2 quarters · filed 2022-05-16 | -$37.19M derived: sum of 3 quarters · filed 2022-05-16 | -$45.55M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | -$13.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$23.21M derived: sum of 2 quarters · filed 2022-03-31 | -$31.57M derived: sum of 3 quarters · filed 2022-03-31 | -$39.44M 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$10.08M 10-Q · filed 2021-11-10 | -$18.44M derived: sum of 2 quarters · filed 2021-11-10 | -$26.30M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$8.36M 10-Q · filed 2021-08-10 | -$16.22M 10-Q · filed 2021-08-10 | |||
| 2020-03-31 | -$7.86M 10-Q · filed 2021-05-13 |